Evaluation of a New Regional Organization to Promote Access to Renal Transplantation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2023-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with terminal chronic kidney disease (CRD) need renal function supplementation, namely dialysis or renal transplantation. Transplantation is the most efficient and cost-effective treatment. Early and equitable access to transplantation is a public health issue. Access to transplantation is facilitated by early and systematic information and assessment of patients for inclusion in the national waiting list for transplantation prior to the onset of dialysis, and by the development of transplantation from living donors. In France, there are wide disparities in access to national waiting list registration and transplantation. One of the causes of these inequalities in access would be the disparity in referral practices to a transplant medical and surgical team authorized to register the individual on the national waiting list.

The aim of the TRACE study is to evaluate the impact of a new regional organization promoting renal transplantation on access to renal transplantation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Preemptive Living Donor Renal Transplantation on Quality of Life , Occupational Rehabilitation and Societal Participation of Transplant Recipients

NCT02893475

ESRD

COMPLETED

Impact of PREMs in the Shared Decision Process for Renal Replacement Treatment Methods.

NCT06819345

Chronic Kidney Disease, Stage 4 (Severe) Chronic Kidney Disease, Stage 5

ACTIVE_NOT_RECRUITING

Geriatric Assessment for Older Kidney Transplantation Candidates

NCT05395247

Chronic Kidney Diseases

RECRUITING

Improved Accessibility to the Renal Transplant List

NCT03934554

Chronic End Stage Renal Failure

UNKNOWN

Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN

NCT03652402

Kidney Transplant Rejection Kidney Transplantation Risk Stratification +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Patients supported without regional organization for promotion of renal transplantation Setting : French Auvergne Rhone Alpes region and French Center region

No interventions assigned to this group

Intervention group

Patients supported with the regional organization for promotion of renal transplantation Setting : French Auvergne Rhone Alpes region

Regional organization for promotion of renal transplantation

Intervention Type OTHER

Early identification of candidates for renal transplantation

* with the help of a care coordinator Inform all patients appropriately about the techniques of renal function supplementation
* delivered by expert patients and a care coordinator Assist the nephrologists in patient graft pathway
* Multidisciplinary assessment of patients in dedicated web-conferencing meetings bringing together nephrologists and transplant team (" WebRCP of kidney transplant orientation")
* Helping to carry out the pre-graft assessments of patients by a care coordinator

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Regional organization for promotion of renal transplantation

Early identification of candidates for renal transplantation

* with the help of a care coordinator Inform all patients appropriately about the techniques of renal function supplementation
* delivered by expert patients and a care coordinator Assist the nephrologists in patient graft pathway
* Multidisciplinary assessment of patients in dedicated web-conferencing meetings bringing together nephrologists and transplant team (" WebRCP of kidney transplant orientation")
* Helping to carry out the pre-graft assessments of patients by a care coordinator

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient older than 18 years and younger than 85 years.
* Entered in the French Network Epidemiology and Information in Nephrology register
* Renal function supplementation begun in 2013 -- 2014 (period before regional organization implementation) or in 2018 -- 2019 (period after regional organization implementation).